ArticleAsian Pacific journal of cancer prevention : APJCP2026
Role of Cyanidin 3-glucoside Extract in the Induction of Cytotoxicity and Apoptosis in a Rat Bladder Cancer Cell Line.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study focused on organisms that produce natural bioactive compounds that are environmentally friendly alternatives to chemical treatments. These compounds include flavonoids derived from marine algae, including anthocyanins. Cyanidin-3-glucoside (C3G) is a natural pigment-protein complex capable of inhibiting or eradicating the proliferation of malignant cells, both in vivo and in vitro.
methodsThis includes the AY-27 rat (BC) bladder cancer cell line. Its potential effects on inhibiting the production of isolated rat bladder tumor cells and activating cellular pathways were studied, including cytotoxicity, apoptosis, the p53 pathway, mitochondrial wall loss pathway, and partial fusion. Result: The present study documented a peak mortality rate of 84.43% in the toxicity pathway on the maximum dose of 100 µg/ml of C3G. The minimum mortality rate of 9.45% was recorded at the maximum C3G concentration of 6.25 µg/ml. In the apoptotic process, dead cells were evaluated for DNA damage. C3G promotes mitochondrial failure in AY-27 cells via the mitochondrial pathway, leading to a reduction in mitochondrial membrane potential compared to untreated AY-27 cells.
conclusionThe study's findings showed that C3G increased p53 gene expression in AY-27 cells during the p53 pathway. The data in the tables and figures reveal that increasing the dose or concentration of C3G over time has a lethal effect on bladder cancer cells. The results indicate that C3G promotes localized apoptosis, thereby inhibiting and slowing down the progression of bladder cancer. These findings suggest that C3G could be an active natural treatment for BC in rats, with potential for further development by international pharmaceutical companies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.